 | Up a level |
Jump to: Journal Article
Number of items: 1.
Journal Article
Walewski, J., Hellmann, A., Siritanaratkul, N., Ozsan, G. H., Ozcan, M., Chuncharunee, S., Goh, A. S., Jurczak, W., Koren, J., Wang, B., Singh, S., Huebner, D. and Engert, A. (2016). SINGLE-ARM STUDY OF BRENTUXIMAB VEDOTIN IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA WHO ARE INELIGIBLE FOR STEM CELL TRANSPLANTATION OR MULTIAGENT CHEMOTHERAPY. Haematologica, 101. S. 56 - 57. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078